Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Therapie|December 22, 2024
Monitoring opioid analgesic misuse, abuse and dependence: What to the data from addictovigilance tell us about the situation in France?Maryse Lapeyre-Mestre, Celian Bertin, Constança Jalles, et al.Therapie|March 19, 2025
Intravitreal vascular endothelial growth factor inhibitors and cardiovascular adverse drug reactions: Added value of the data of the French pharmacovigilance spontaneous reporting assessmentAurélie Bobet, Leila Chebane, Annie-Pierre Jonville-Bera, et al.Fundamental & Clinical Pharmacology|December 15, 2021
Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the marketJules Baudot, Thomas Soeiro, Marine Tambon, et al.Fundamental & Clinical Pharmacology|November 27, 2021
Antidepressants abuse in subjects with opioid use disorders: A 10-year study in the French OPPIDUM programRobinson Gravier Dumonceau, Thomas Soeiro, Clémence Lacroix, et al.Therapie|November 13, 2023
Antibiotic-induced neurological adverse drug reactionsClémence Lacroix, Tessa Pietri, Vincent Montero, et al.CNS Drugs|July 11, 2024
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022Clément Garnier, Martin Schein, Clémence Lacroix, et al.British Journal of Clinical Pharmacology|March 23, 2022
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance dataAnne Roussin, Thomas Soeiro, Charlotte Fouque, et al.Journal of Psychopharmacology (Oxford, England)|February 23, 2026
Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023Tiphaine Raingeard, Thomas Soeiro, Caroline Victorri-Vigneau, et al.Therapie|December 28, 2020
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacologyClémence Lacroix, Thomas Soeiro, Marguerite Le Marois, et al.Therapeutic Advances in Drug Safety|May 19, 2025
Can large language models detect drug-drug interactions leading to adverse drug reactions?Justine Sicard, François Montastruc, Coline Achalme, et al.Pageof 3